21st Jan 2005 17:24
GlaxoSmithKline PLC21 January 2005 Director's Interests I give below details of changes in directors' interests in the Ordinary Sharesof GlaxoSmithKline plc. 17 December 2004 The Administrators of the Trust notified the Company on 20 January 2005 that 973 Ordinary shares in the Company had been sold on 17 December 2004 on behalf of a participant in the SmithKline Beecham Bonus Investment Plan at a price of £11.69. The Trust also notified the Company on 20 January 2005 that 1,389 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Bonus Investment Plan. 13 January 2005 The Administrators of the Trust notified the Company on 20 January 2005 that following reinvestment of the cash dividend paid to shareholders on 06 January 2005, 1,127 Ordinary Shares in the Company had been purchased for participants in the SmithKline Beecham Bonus Investment Plan at a price of £12.43 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 20 January 2005 that 929 Ordinary shares had been transferred from the Trust to participants in the SmithKline Beecham Unapproved Share Match Plan. 17 January 2005 The Administrators of the Trust notified the Company on 20 January 2005 that following reinvestment of the cash dividend paid to shareholders on 06 January 2005, 7,560 Ordinary Shares in the Company had been purchased for participants in the GlaxoSmithKline Annual Investment Plan at a price of £12.15 The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, John Coombe is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. S M BicknellCompany Secretary 21 January 20050 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline